If you have trouble viewing this email, read the online version
 
Hi Colleague,
 
Attend Europe’s largest, most respected market access and pricing conference to benchmark your strategic decision making. Hear from an unprecedented number of international payers at our congress as we celebrate 11 successful years in 2019.
 
Learn how to prepare your market access strategy for the ever changing global healthcare market and understand the diverse payer landscape and how to influence decision making with insight from key payer organisations. 
 
 The World Pharma Pricing and Market Access Congress transpiring on the 19 - 20th March in Amsterdam is Europe’s largest international event discussing:
  • Drug Pricing
  • Reimbursement
  • Contract Tendering
  • Evidence
  • Rare Diseases
  • HTA
  • Emerging Markets
  • Managed Entry Agreements
  • Advanced Therapies
  • Contacting and Price Tendering
  • Payer and Patient Engagement
  • Medical and Governmental Affairs
  • and for this year’s event a new Biosimilars track.
With over 180 speakers already on board this is an all-encompassing event to help you understand the future of pricing and sustainable drug development.
 
220+ SPEAKERS 700+ ATTENDEES  6 TRACKS
 
 
Here are some of the confirmed 200+ speakers :
Jeff Myers
Ex CEO
Medicaid Health Plans of America
Luc Boileau
Président-directeur general
INESSS
Bharat Tewarie
Chief Marketing Officer and Executive Vice President UCB
Carla Deakin
Associate Director – Accelerated Access Collaborative Secretariat & NICE Office for Market Access
NICE
Bart Vermeulen
Deputy Director Healthcare at Office of the Minister of Social Affairs and Public Health
Belgian Federal Government 
Thomas Mueller
Head of Directorate General 1 "Drugs, Medical Devices, Biotechnology
Federal Ministry of Health for Germany
Francois Meyer
Advisor to the President | International Affairs
HAS
Charles-Etienne de Cidrac
Director Health
AXA
Daniel Knecht
CMO, Head of Clinical Strategy Aetna
Dan Pettitt
Global Head, Immunology Market Access (Health Economics and Reimbursement) & Policy J&J
Andres Pichon-Riviere
Executive Director Institute for Clinical Effectiveness and Health Policy
Ariella Adijes Toren
Director of Medicine and Medical Technologies, HMOs department
Ministry of health, Israel
Saira Jan
Director of Pharmacy Strategy and Clinical Integration
Horizon Blue Cross Blue Shield
We have an Early Bird Offer available so book now and save!
 
Looking forward to seeing you in Amsterdam!
 
Chris Shanks
Project Manager, Terrapinn Ltd
T: +44 (0) 207 092 1151
E: chris.shanks@terrapinn.com

 

This email advertisement was sent on behalf of TERRAPINN by HealthEconomics.Com, 449 S. Mill View Way, Ponte Vedra Beach, FL 32082.
If you don't wish to receive further Industry Leaders News Updates from us, you may immediately unsubscribe from this list here , or send your request in writing to the address above. Read more about our privacy policy here. You may also request a copy in writing using the address above.